Evolus (EOLS) Price & Analysis

Compare

545 Followers

EOLS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$8.65 - $17.82

Previous CloseN/A

Volume344.54K

Average Volume (3M)917.34K

Market Cap

$574.48M

Enterprise Value$687.57M

Total Cash (Recent Filing)$61.74M

Total Debt (Recent Filing)$183.40M

Price to Earnings (P/E)―

Beta1.09

Next Earnings

Nov 11, 2025

EPS Estimate

-0.17

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.25

Shares Outstanding64,475,586

10 Day Avg. Volume1,246,940

30 Day Avg. Volume917,338

Financial Highlights & Ratios

PEG Ratio0.54

Price to Book (P/B)123.99

Price to Sales (P/S)2.57

P/FCF Ratio-35.16

Enterprise Value/Market Cap1.20

Enterprise Value/Revenue2.48

Enterprise Value/Gross Profit3.71

Enterprise Value/Ebitda-13.18

Forecast

1Y Price Target

$24.00

Price Target Upside169.36% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Market ExpansionEvolus expanded into the injectable hyaluronic acid (HA) gel market with two capital efficient distribution agreements.

Product LaunchThe company remains in a great position with the launch of a second product and a strengthened balance sheet.

Revenue GrowthEOLS is expected to deliver ~30% top-line growth by maintaining its current market share.

Bears Say

Macroeconomic ConcernsSome investors may be concerned with the macro trends, given the significant volatility in the capital markets, consumer sentiment, and tariffs noise.

Management ChangesCFO Sandra Beaver will be resigning from the company and Evolus has initiated the process to identify a successor.

Evolus News

Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz

The major averages were higher near noon, led by the Nasdaq, as investors reacted to another heavy dose...

1d ago

Evolus price target lowered to $18 from $21 at BTIG

BTIG analyst Sam Eiber lowered the firm’s price target on Evolus (EOLS) to $18 from $21 and keeps...

1d ago

EOLS

Evolus cut to Hold at Needham after ‘significant’ Jeuveau downturn

Needham downgraded Evolus (EOLS) to Hold from Buy and removed the firm’s prior $22 price target The company’s...

1d ago

EOLS

Evolus downgraded to Hold from Buy at Needham

Needham analyst Serge Belanger downgraded Evolus (EOLS) to Hold from Buy and removed the firm’s prior $22 price...

1d ago

EOLS

Evolus price target lowered to $20 from $27 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Evolus (EOLS) to $20 from $27 and keeps a Buy...

2d ago

EOLS

Evolus reports Q2 EPS (27c), consensus (9c)

Reports Q2 revenue $69.4M, consensus $82.0M. “U.S. toxin demand softened in the second quarter, driven by reduced patient...

2d ago

EOLS

Evolus sees FY25 revenue $295M-$305M, consensus $348.2M

16:24 EDT Evolus (EOLS) sees FY25 revenue $295M-$305M, consensus $348.2M Published first on TheFly – the ultimate source...

2d ago

EOLS

Evolus down 25% at $6.66 after Q2 earnings miss

16:24 EDT Evolus (EOLS) down 25% at $6.66 after Q2 earnings miss Published first on TheFly – the...

2d ago

EOLS

Evolus launches Nuceiva neurotoxin in France through Symatese partnership

Evolus (EOLS) announced it has partnered with Symatese to commence distribution of Nuceiva, or botulinum toxin type A,...

29d ago

EOLS

Evolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines

Evolus, Inc. (($EOLS)) announced an update on their ongoing clinical study. Evolus, Inc. is conducting a non-interventional post-authorization...

6h ago

EOLS

Evolus, Inc. Faces Financial Instability Amid Economic Uncertainty and Consumer Spending Risks

Evolus, Inc. (EOLS) has disclosed a new risk, in the Demand category. Evolus, Inc. faces significant business risks...

17h ago

EOLS

Evolus, Inc. Earnings Call: Mixed Sentiments and Strategic Goals

Evolus, Inc. (($EOLS)) has held its Q2 earnings call. Read on for the main highlights of the call....

22h ago

EOLS

Evolus: Strategic Growth and Cost Optimization Support Buy Rating Amid Market Challenges

In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Evolus, with a...

1d ago

EOLS

Evolus, Inc. Reports Q2 2025 Financial Results

Evolus, Inc. ( ($EOLS) ) has released its Q2 earnings. Here is a breakdown of the information Evolus,...

2d ago

EOLS

EOLS FAQ

What was Evolus, Inc.’s price range in the past 12 months?

Evolus, Inc. lowest stock price was $8.65 and its highest was $17.82 in the past 12 months.

What is Evolus, Inc.’s market cap?

Evolus, Inc.’s market cap is $574.48M.

When is Evolus, Inc.’s upcoming earnings report date?

Evolus, Inc.’s upcoming earnings report date is Nov 11, 2025 which is in 96 days.

How were Evolus, Inc.’s earnings last quarter?

Evolus, Inc. released its earnings results on Aug 05, 2025. The company reported -$0.247 earnings per share for the quarter, missing the consensus estimate of -$0.099 by -$0.148.

Is Evolus, Inc. overvalued?

According to Wall Street analysts Evolus, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Evolus, Inc. pay dividends?

Evolus, Inc. does not currently pay dividends.

What is Evolus, Inc.’s EPS estimate?

Evolus, Inc.’s EPS estimate is -0.17.

How many shares outstanding does Evolus, Inc. have?

Evolus, Inc. has 64,475,586 shares outstanding.

What happened to Evolus, Inc.’s price movement after its last earnings report?

Evolus, Inc. reported an EPS of -$0.247 in its last earnings report, missing expectations of -$0.099. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Evolus, Inc.?

Currently, no hedge funds are holding shares in EOLS

Evolus Stock Smart Score

Neutral

Fundamentals

Return on Equity

-9999.00%

Trailing 12-Months

Asset Growth

-2.13%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Evolus, Inc.

Evolus, Inc. (EOLS) is a performance beauty company that focuses on delivering innovative aesthetic products. The company's flagship product, Jeuveau, is a prescription medicine used in facial aesthetics to improve the appearance of moderate to severe frown lines between the eyebrows, also known as glabellar lines. Evolus specializes in the self-pay aesthetic market, emphasizing the millennial consumer segment through its contemporary branding and digital marketing strategies.

Evolus (EOLS) Earnings & Revenues

Historic Earnings Reports

EOLS Company Deck

EOLS Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Evolus reported strong revenue growth and a successful product launch, with significant customer engagement and financial repositioning. However, challenges include reduced market growth expectations, tariff impacts, and increased operating expenses. Despite these challenges, the company's strategic execution and market share gains indicate a positive outlook.View all EOLS earnings summaries

EOLS Stock 12 Month Forecast

Average Price Target

$24.00

▲(169.36% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","13":"$13","18":"$18","23":"$23","28":"$28"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$21.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,13,18,23,28],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.15,10.523076923076923,11.896153846153847,13.26923076923077,14.642307692307693,16.015384615384615,17.38846153846154,18.761538461538464,20.134615384615387,21.50769230769231,22.880769230769232,24.253846153846155,25.626923076923077,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.15,10.292307692307693,11.434615384615384,12.576923076923077,13.71923076923077,14.861538461538462,16.003846153846155,17.146153846153844,18.28846153846154,19.43076923076923,20.573076923076925,21.715384615384615,22.857692307692307,{"y":24,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.15,10.061538461538461,10.973076923076924,11.884615384615385,12.796153846153846,13.707692307692309,14.61923076923077,15.53076923076923,16.442307692307693,17.353846153846156,18.265384615384615,19.176923076923075,20.088461538461537,{"y":21,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.04,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.89,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.02,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.75,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.51,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.04,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.97,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.99,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.97,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.15,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >